DOMINICI, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 41.679
EU - Europa 21.926
AS - Asia 21.851
SA - Sud America 3.360
AF - Africa 583
OC - Oceania 115
Continente sconosciuto - Info sul continente non disponibili 30
Totale 89.544
Nazione #
US - Stati Uniti d'America 40.788
SG - Singapore 6.767
CN - Cina 5.627
IT - Italia 5.591
GB - Regno Unito 4.929
SE - Svezia 3.442
HK - Hong Kong 2.718
VN - Vietnam 2.565
BR - Brasile 2.448
DE - Germania 2.041
FI - Finlandia 1.114
RU - Federazione Russa 939
FR - Francia 787
KR - Corea 705
TR - Turchia 624
UA - Ucraina 613
IN - India 542
IE - Irlanda 536
ID - Indonesia 496
CA - Canada 464
AR - Argentina 324
NL - Olanda 318
BG - Bulgaria 294
MX - Messico 288
JP - Giappone 285
BD - Bangladesh 261
PL - Polonia 187
ES - Italia 181
ZA - Sudafrica 172
IQ - Iraq 171
BE - Belgio 170
PK - Pakistan 143
AT - Austria 126
AE - Emirati Arabi Uniti 117
EC - Ecuador 117
AU - Australia 109
CO - Colombia 106
CL - Cile 105
VE - Venezuela 103
LT - Lituania 91
MY - Malesia 88
CZ - Repubblica Ceca 84
RO - Romania 80
MA - Marocco 75
UZ - Uzbekistan 68
KE - Kenya 67
PH - Filippine 64
TW - Taiwan 64
EG - Egitto 63
CH - Svizzera 62
IR - Iran 58
SA - Arabia Saudita 56
JO - Giordania 55
PE - Perù 48
PY - Paraguay 48
AL - Albania 46
DZ - Algeria 44
IL - Israele 44
TN - Tunisia 43
NO - Norvegia 39
TH - Thailandia 37
NP - Nepal 34
PT - Portogallo 33
SI - Slovenia 30
UY - Uruguay 30
AZ - Azerbaigian 27
LB - Libano 27
KZ - Kazakistan 25
RS - Serbia 25
DO - Repubblica Dominicana 24
BO - Bolivia 23
OM - Oman 23
BY - Bielorussia 22
CR - Costa Rica 22
DK - Danimarca 19
HR - Croazia 19
SY - Repubblica araba siriana 19
ET - Etiopia 18
GR - Grecia 18
JM - Giamaica 18
SN - Senegal 18
EU - Europa 16
QA - Qatar 16
SK - Slovacchia (Repubblica Slovacca) 16
CY - Cipro 15
NG - Nigeria 14
PA - Panama 14
EE - Estonia 13
HU - Ungheria 13
AM - Armenia 12
CI - Costa d'Avorio 12
KG - Kirghizistan 12
PS - Palestinian Territory 12
BZ - Belize 11
GE - Georgia 11
BH - Bahrain 10
HN - Honduras 10
LK - Sri Lanka 10
MD - Moldavia 10
KW - Kuwait 9
Totale 89.347
Città #
Ashburn 4.368
Singapore 4.348
Santa Clara 3.794
Fairfield 3.781
Southend 2.741
Hong Kong 2.638
Chandler 2.282
Woodbridge 1.977
Stockholm 1.834
Hefei 1.792
San Jose 1.605
Houston 1.588
Seattle 1.367
Wilmington 1.201
Cambridge 1.173
Ann Arbor 1.113
London 1.051
Beijing 1.039
Nyköping 979
Jacksonville 974
Los Angeles 888
Dearborn 859
Ho Chi Minh City 859
Chicago 840
Helsinki 837
Council Bluffs 751
Modena 687
Seoul 660
New York 648
Hanoi 613
The Dalles 579
Dallas 537
Munich 524
Dublin 499
Bologna 478
San Diego 429
Milan 388
Jakarta 360
Lauterbourg 320
Salt Lake City 318
Izmir 310
Princeton 306
Moscow 295
Shanghai 285
Sofia 279
Frankfurt am Main 242
Buffalo 224
São Paulo 222
Tokyo 210
Eugene 200
Rome 196
Orem 180
Parma 155
Tampa 151
Elk Grove Village 150
Phoenix 139
Reggio Emilia 139
Warsaw 137
Boardman 134
Redwood City 130
Des Moines 126
Berlin 125
Brussels 122
Nuremberg 120
Falls Church 119
Bremen 114
Mexico City 113
Columbus 112
Mcallen 109
Fremont 107
Guangzhou 107
Da Nang 106
Montréal 103
Montreal 102
Amsterdam 101
Chennai 101
Johannesburg 101
Rio de Janeiro 97
Denver 94
Lancaster 94
Atlanta 92
Brooklyn 91
Haiphong 89
Toronto 89
Kent 87
Manchester 86
Redondo Beach 76
Sterling 71
Miami 64
Turku 64
Poplar 63
Vienna 63
Portsmouth 61
Dong Ket 60
Baghdad 59
Naples 59
Florence 58
Hillsboro 58
Mumbai 58
Grafing 56
Totale 61.380
Nome #
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. 2.188
0.1 grams of sub-cutaneous adipose tissue (SCAT) as source of adult multipotent mesenchymal stromal cells (MSC) for cell-based therapies 700
Dynamic cultivation of mesenchymal stem cell aggregates 652
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement 507
CD271 Mediates Stem Cells to Early Progeny Transition in Human Epidermis 486
Impressive response to dose-dense chemotherapy in a patient with NUT midline carcinoma 461
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy 457
Rigenerand srl - Spin off Università di Modena e Reggio Emilia 424
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance. 424
GD2 expression in breast cancer. 415
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 413
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 407
GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. 404
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 403
Autologous Porcine Bone Marrow Mesenchymal Cells for Reconstruction of a Resorbed Alveolar Bone: A Preclinical Model in Mini-Pigs 401
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients 394
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 389
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies 384
MSC and Tumors: Homing, Differentiation and Secretion Influence The Therapeutic Potentials 378
The puzzling situation of hospital exemption for advanced therapy medicinal products in Europe and stakeholders' concerns 378
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 377
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing 376
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 374
Delayed marrow infusion in mice enhances hematopoietic and osteopoietic engraftment by facilitating transient expansion of the osteoblastic niche 373
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 373
Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood 370
cGMP-compliant transportation conditions for a prompt therapeutic use of marrow mesenchymal stromal/stem cells 369
A novel function for amniotic fluid: original or authentic? 362
Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticus 362
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells 362
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 357
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors 357
Le Cellule Staminali Mesenchimali: Aspetti Biologici ed Approcci Terapeutici 355
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 354
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 349
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 346
Mesenchymal progenitors aging highlights a mir-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis 342
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 342
Phase I study of intraperitoneal MHC unrestricted adoptive cell therapy with TALL-104 cells in patients with peritoneal carcinosis 341
An alternative approach to investigate biofilm in medical devices: A feasibility study 338
In vitro differentiation of human amniotic epithelial cells into insulin-producing 3D spheroids 337
Body composition and inflammation impact in non-small cell lung cancer patients treated by first-line immunotherapy 337
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT) 335
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 333
Potency biomarker signature genes from multiparametric osteogenesis assays: Will cGMP human bone marrow mesenchymal stromal cells make bone? 330
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 330
Transplanted murine long-term repopulating hematopoietic cells can differentiate to osteoblasts in the marrow stem cell niche 329
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM 329
Comparison of single and dual platform methodologies for the estimation of CD34+ hematopoietic progenitor cells: correlation with colony assay 328
Clarification of the nomenclature for MSC: the international society for cellular therapy position statement 327
Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac/DIABLO from the mitochondria 327
Human mesenchymal stem cell combined with a new strontium-enriched bioactive glass: An ex-vivo model for Bone Regeneration 327
Tumor Stroma Manipulation By MSC 325
Osteopoietic engraftment after bone marrow transplantation: Effect of inbred strain of mice 324
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells. 323
METHOD FOR PRODUCTION OF ANTI-TUMOR TRAIL PROTEIN 318
International society for cellular therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials 318
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness? 318
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas 317
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy 316
Cytokine-Induced Osteopoietic Differentiation of Transplanted Marrow Cells 311
Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE). 311
Label-free toxicology screening of primary human mesenchymal cells and iPS-derived neurons 310
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation 309
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? 308
A new bioactive glass with extremely high crystallization temperature and outstanding biological performance 307
Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression 306
Angiogenesis in multiple myeloma: Correlation between in vitro endothelial colony growth (CFU-En) and clinical biological features 306
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 306
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 305
Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration 304
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 304
Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial 303
Transgenic Mice with Pancellular Enhanced Green Fluorescent Protein Expression in Primitive Hematopoietic Cells and All Blood Cell Progeny 301
Detection of microparticles from human red blood cells by multiparametric flow cytometry 300
Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis 300
How do mesenchymal stromal cells exert their therapeutic benefit? 297
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 294
Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. 294
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 293
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 289
GD2 CAR T cells against human glioblastoma 289
Precision Medicine in Lung Cancer: Challenges and Opportunities in Diagnostic and Therapeutic Purposes. 287
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma 287
Mineralization by mesenchymal stromal cells is variously modulated depending on commercial platelet lysate preparations 285
Understanding Tumor-Stroma Interplays for Targeted Therapies by Armed Mesenchymal Stromal Progenitors: The Mesenkillers. 285
Bone marrow mesenchymal cells: biological properties and clinical applications. 284
Cell therapies for pancreatic beta-cell replenishment. 284
Donor Cell-Derived Osteopoiesis Originates from a Self-Renewing Stem Cell with a Limited Regenerative Contribution after Transplantation 284
Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 29-30 September 2006, Tübingen, Germany 282
Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany. 282
Mesenchymal Stromal/Stem Cells from Tissue Repair to Destruction of Tumor Cells 281
Rare breast cancer subtypes: Histological, molecular, and clinical peculiarities 280
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 279
A new Approach to Investigate Biofilm Formation in Medical Devices 279
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 278
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 278
17th Annual ISCT Meeting. May 18-21, 2011. Rotterdam 277
CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? 277
Multicentre validation of an immune-inflammation-based nomogram to predict survival in western resectable gastroesophageal adenocarcinoma: The NOMOGAST 276
Totale 36.084
Categoria #
all - tutte 342.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 342.226


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.114 0 0 0 0 0 0 0 0 0 890 792 432
2021/20226.659 365 738 581 348 284 474 400 410 653 525 1.072 809
2022/20237.308 824 784 544 663 742 907 191 654 1.160 136 404 299
2023/20245.124 257 309 365 495 823 502 513 600 154 196 287 623
2024/202516.829 497 226 488 1.146 2.697 2.488 1.410 981 1.964 1.134 1.625 2.173
2025/202633.490 2.334 1.402 3.053 4.292 5.756 2.171 4.231 1.802 5.062 3.387 0 0
Totale 90.293